Showing 1 - 7 results of 7 for search 'Moody MA', query time: 0.03s
Refine Results
-
1
-
2
-
3
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth by Roskin, KM, Jackson, KJL, Lee, JY, Hoh, RA, Joshi, SA, Hwang, KK, Bonsignori, M, Pedroza-Pacheco, I, Liao, HX, Moody, MA, Fire, AZ, Borrow, P, Haynes, BF, Boyd, SD
Published 2020Journal article -
4
Lack of IgA envelope-reactive antibody producing cells in terminal ileum in early and chronic HIV-1 infection by Trama AM, Liao H, Foulger A, Marshall DJ, Whitesides JF, Parks R, Meyerhoff R, Lloyd KE, Donathan M, Lucas J, Soderberg K, Kepler TB, Vandergrift N, Yates N, Tomaras GD, Moody MA, Haynes BF
Published 2012-09-01Article -
5
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family by Bonsignori M, Pollara J, Moody MA, Kepler TB, Chen X, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim JH, Michael NL, Montefiori DC, Liao H, Ferrari G, Haynes BF
Published 2012-09-01Article -
6
S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects by Markowitz M, Margolis DM, Shea TC, Kelsoe GH, Moody MA, Tomaras GD, Gao F, Yang Y, Marshalls DJ, Whitesides JF, Amos J, Parks R, Derosa K, Nagel A, Chen X, Dixon A, Liao H, Munshaw S, Goepfert P, Shaw G, Haynes BF, Kepler TB
Published 2009-10-01Article -
7
Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial by Williams WB, Jones K, Krambrink A, Grove D, Liu P, Yates NL, Moody MA, Ferrari G, Pollara J, Moodie Z, Morgan CA, Liao H, Montefiori DC, Ochsenbauer C, Kappes J, Hammer S, Mascola J, Koup R, Corey L, Nabel G, Gilbert P, Churchyard G, Keefer M, Graham BS, Haynes BF, Tomaras GD
Published 2012-09-01Article